U.S. market Closed. Opens in 16 hours 33 minutes

NBSE | NeuBase Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-302009-09-302008-09-302007-09-302005-12-312004-12-312003-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A389.00K7.15M5.70M3.84M
Cost of Revenue1.26M575.52K280.46K128.37K13.90M23.78M24.60MN/AN/AN/AN/AN/AN/AN/AN/A1.25B1.20MN/AN/A
Gross Profit-1.26M-575.52K-280.46K-128.37K-13.90M-23.78M-24.60MN/AN/AN/AN/AN/AN/AN/AN/A-1.25B5.95M5.70M3.84M
Operating Expenses33.32M26.57M17.07M26.34M9.08M23.85M25.31M17.47M9.12M4.62M3.29M1.24M1.02M932.88K640.00K-2.37M-5.56M-3.92M-2.60M
Selling, General & Admin11.87M12.20M10.12M9.10M3.63M5.28M7.66M7.51M5.13M2.01M1.66M721.43K761.57K932.88K640.00K2.71M1.46M1.32M1.12M
Research & Development21.45M14.36M6.95M17.24M4.32M17.41M16.46M8.78M3.99M2.61M1.63M521.97K254.02KN/AN/A1.12B1.22MN/AN/A
Other Operating Expenses-166.87K450.31K412.37K12.97M592.58K1.17M-471.98K1.18M2.80M1.09M649.29K279.03KN/AN/AN/A-5.08M-8.24M-5.24M-3.72M
Operating Income-33.32M-26.57M-17.07M-26.34M-13.90M-23.78M-24.60M-17.81M-9.12M-4.62M-3.29M-1.24M-1.02M-932.88K-640.00K4.38M17.51M12.57M8.42M
Other Expenses / Income-458.11K1.16M-315.21K-621.84K-12.74M-30.93K-459.88K2.61MN/A-1.03M1.83M-3.86M1.51M68.43K11.00K1.25B-17.38M-9.16M-5.98M
Before Tax Income-33.78M-25.41M-17.38M-26.96M-13.24M-23.81M-25.77M-15.20M-9.13M-5.65M-1.45M-5.10M494.38K-864.45K-629.00K2.76M128.00K454.67K106.61K
Income Tax Expenses458.11K258.11K-123.27K128.95K8.98M-109.24K459.88K-2.38M-8.48K1.03M-1.83M3.86M-1.53M-94.23K-665.00K10.68M52.14K169.64K4.75K
Net Income-34.23M-25.67M-17.26M-27.09M-13.24M-23.81M-25.77M-15.20M-9.13M-5.65M-1.45M-5.10M494.38K-864.45K25.00K-6.30M75.86K285.03K101.85K
Interest Expenses24.05K32.33K7.69K128.95KN/A30.92K1.17M5.98K5.58K4.69K1.82K2.43K21.49K25.80K-11.00K1.62M4.01K3.68K14.02K
Basic Shares Outstanding1.62M1.37M981.01K413.58K141.46K111.93K78.37K71.01K55.35K46.77K35.61K32.22K27.35K21.04K21.04K11.88K2.45K2.45K2.44K
Diluted Shares Outstanding1.62M1.37M981.01K413.58K141.46K111.93K78.37K71.01K55.35K46.77K35.61K32.22K27.35K21.04K21.04K11.88K2.45K2.45K2.44K
EBITDA-32.49M-25.92M-16.92M-26.21M-3.13M-22.75M-24.12M-16.39M-8.67M-4.53M-3.20M-1.16M-995.15K-932.88K-651.00K4.54M17.57M12.62M8.47M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1,167.10%245.78%221.44%220.40%
EBIT-33.75M-25.38M-17.38M-26.83M-4.25M-23.89M-24.14M-17.57M-9.13M-4.62M-3.29M-1.24M-1.02M-932.88K-651.00K5.99M132.01K458.35K120.62K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1,540.62%1.85%8.04%3.14%
Financial Year End2022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-302009-09-302008-09-302007-09-302005-12-312004-12-312003-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙